XML 8 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 260,630 $ 193,513
Accounts receivable 30,546 14,454
Receivables from collaboration arrangement 60,512 69,621
Inventory 34,236 40,737
Prepaid expenses 12,650 21,630
Other current assets 2,047 4,264
Total current assets 400,621 344,219
Property and equipment, net 544 483
Equity method investments 73,549 116,546
Equity and long-term investments 434,169 444,432
Capitalized fees paid, net 73,416 83,784
Right-of-use assets 2,789 2,536
Goodwill 17,905 17,905
Intangible assets 210,944 230,335
Deferred tax assets, net 14,875 0
Other assets 2,800 3,267
Total assets 1,231,612 1,243,507
Current liabilities:    
Accounts payable 4,170 6,717
Accrued personnel-related expenses 5,965 7,020
Accrued interest payable 833 3,422
Deferred revenue 717 1,277
Convertible subordinated notes due 2025, net of issuance costs 191,843 0
Income Taxes Payable 2,623 0
Other accrued liabilities 17,599 19,698
Total current liabilities 223,750 38,134
Long-term debt, net of discount and issuance costs 255,972 446,234
Other long-term liabilities 71,449 71,870
Deferred tax liabilities, net 0 563
Income tax payable, long-term 11,899 11,751
Commitments and contingencies (Note 12)
Stockholders' equity:    
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding 0 0
Common stock: $0.01 par value, 200,000 shares authorized, 62,601 and 63,307 issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 626 633
Treasury stock: at cost, nil and 32,005 shares as of September 30, 2024 and December 31, 2023, respectively 0 (393,829)
Additional paid-in capital 690,045 1,093,340
Accumulated deficit (22,129) (25,189)
Total stockholders' equity 668,542 674,955
Total liabilities and stockholders' equity $ 1,231,612 $ 1,243,507